Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Selling, general and administrative

Equity earnings (loss) in AmerisourceBergen

Impairment of goodwill

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Walgreens

Duane Reade is a subsidiary of Walgreens Boots Alliance, is a chain of pharmacy and convenience stores, primarily located in New York City, known for its high volume small store layouts in densely populated Manhattan locations.

Duane Reade

Boots UK is a pharmacy chain in the United Kingdom, Ireland, Norway, Thailand and other territories. Boots became a subsidiary of the new company, Walgreens Boots Alliance, on 31 December 2014.

Boots UK

Alliance Healthcare was formerly Alliance UniChem, wholesales, distributes, and retails pharmaceutical, surgical, medical, and healthcare products throughout Europe. The company supplies more than 110,000 pharmacies, doctors, health centres and hospitals from over 288 distribution centres in 11 countries. The company is a wholly owned subsidiary of Walgreens Boots Alliance, which was formed by the merger of Walgreens with its former parent Alliance Boots in 2014. Alliance Boots had itself been formed in 2006 by the merger of Boots Group and Alliance UniChem on 31 July 2006. Alliance UniChem was rebranded Alliance Healthcare in 2009.

Alliance Healthcare

Walgreens Boots Alliance, Inc. engages in the provision of healthcare and retail pharmacy services. It operates through the following segments: United States Retail Pharmacy, International, and United States Healthcare. The US Retail Pharmacy segment includes the operation of retail drugstores, health and wellness services, specialty and home delivery pharmacy services, and equity method investment. The International segment offers pharmacy-led health and beauty retail businesses outside the US and the pharmaceutical wholesaling and distribution business in Germany. The US Healthcare segment delivers improved health outcomes and lower costs for payors and providers through owned and partnered assets. The company was founded by Charles R. Walgreen and John Boot in 1909 and is headquartered in Deerfield, IL.

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Walgreens reports Q1 earnings decline, eyes growth opportunities ahead

Walgreens faces challenges from COVID impacts and investments but is on track to achieve full-year guidance.
Strategic acquisitions and scaling U.S. Healthcare present opportunities for growth and profitability.
Despite first-half declines, the company anticipates improvements in margins and performance in the second half.
Efforts to optimize cash flow and investments position Walgreens for future growth and success.

Walgreens reports 4.5% sales growth in Q2 2023 earnings

Walgreens remains cautiously optimistic about managing potential changes in health plans and anticipates a strong second half of the year. The company is targeting debt reduction and small tuck-on acquisitions in healthcare as capital allocation priorities.

Walgreens (WBA) reports mixed Q3 performance, focuses on profitability

Walgreens (WBA) Q3 2023 earnings call highlights mixed performance with a focus on profitability enhancement.
Strategic partnerships, cost management programs, and capital allocation priorities support long-term value creation.
Challenges in margin pressures, script growth, and operational issues require immediate actions for profitability.
Opportunities lie in unlocking profitability, market developments, and demand for risk-based health care services.

Walgreens appoints new CEO to drive cost savings and script growth opportunities

Walgreens is strategically positioning itself for operational efficiency and cost savings in fiscal year 2024. The company's new CEO, Tim Wentworth, is expected to drive healthcare expertise and cost-effective outcomes. Despite challenges like lower contributions and segment declines, Walgreens is leveraging opportunities for script growth and financial improvement.

Walgreens Q1 Earnings: Navigating Challenges, Focused on Value Creation

Walgreens is navigating challenges in the pharmacy sector while focusing on strategic initiatives to drive value creation and sustainable growth. The company's emphasis on partnerships, cost-saving actions, and a shift towards value-based reimbursement models positions them for future success in the evolving healthcare landscape.

Walgreens reports solid Q2 results, focuses on growth strategies

Walgreens navigates retail challenges with strong operational performance. Focus on cost discipline, portfolio optimization, and cash flow improvement. Strategic decisions to drive growth and unlock value in healthcare areas.

Walgreens Q3 Earnings Miss Expectations Amid Challenges

Walgreens' Q3 2024 earnings call highlighted a challenging quarter with missed expectations, driven by pressures in the retail pharmacy sector and adverse market conditions. CEO Tim Wentworth emphasized ongoing strategic reviews and cost management initiatives as key to navigating these challenges. The company remains committed to transforming its business model to better serve customers and improve operational efficiency.

Walgreens (WBA) reports Q4 earnings, focuses on growth strategies

Walgreens (WBA) focused on financial stability, cost efficiency, and strategic growth initiatives in Q4 2024 earnings call.
The company aims to address challenges like disruptions, inflation, and underperforming stores while leveraging strengths in cash flow and cost-cutting.
Opportunities in store optimization, digital enhancement, and asset monetization are key areas for future growth.
Overall, Walgreens is navigating challenges, leveraging strengths, and pursuing opportunities to enhance financial performance and resilience.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Kinder Morgan

Verizon

Stocks with attractive, sustainable dividend yields are highly desirable to income investors. Moreover, if their stock prices are significantly undervalued, they become even more compelling investments.

3 Undervalued High-Yield Stocks to Buy

CVS Health

Rite Aid

Zacks Retail Pharmacy and Drugstore industry players like CVS, WBA and RAD are likely to gain on the strength of their digital pharmacies.

3 Retail Pharmacy and Drugstore Stocks to Watch in a Growing Industry

Innovative Industrial Properties

AT&T

The newest meeting minutes from the Federal Open Market Committee model a mild recession taking shape later this year. Buying dividend stocks can be a smart way to combat a potentially volatile and uncertain market.

The Fed Is Forecasting a Recession: 3 Surefire, High-Yield Dividend Stocks to Buy Right Now

SPDR Dow Jones Industrial Average ETF

Invesco Dow Jones Industrial Average Dividend ETF

Dow Inc

5 Dogs Of The Dow: Yield, Quality, But Little Momentum

Walgreens pays a dividend that has increased every year for 47 years. Recently, the pace of increase fell significantly.

How Safe Is Walgreens' Dividend in 2023?

Walgreens: Healthcare Segment Growth Potential May Not Offset Overall Weak Margin

Walgreens has recently made several acquisitions in a bid to catch up with CVS. The company has needed to find new business lines to bolster growth.

Should You Buy The Turnaround At Walgreens

Realty Income Corp

Dividend stocks remain at the top of investors' radar. Not only do these companies pay out a portion of their cash flow to shareholders, but many do so consistently.

3 Dividend Stocks With a 5% Yield on Sale Now

Walgreens (WBA) collaborates with Prothena Corporation to support patient awareness, participation and representation in a clinical trial of Prothena's Alzheimer's drug candidate, PRX012.

Walgreens (WBA) Declares Partnership With Prothena Corporation

Prothena

DEERFIELD, Ill. & DUBLIN--(BUSINESS WIRE)--Walgreens and Prothena today announced a collaboration to accelerate patient identification and recruitment for Prothena's ongoing ASCENT-2 multiple ascending dose clinical trial evaluating the safety and tolerability of PRX012, a potential best-in-class anti-amyloid beta antibody under development for the treatment of Alzheimer's disease.

Walgreens and Prothena Partner to Increase Access and Enrollment in Alzheimer's Disease Clinical Trial

The Dow's 30 components tend to be profitable and time tested, which helped the iconic index outperform last year. Two Dow stocks, with respective yields of 5.4% and 6.6%, have sustained catalysts and predictable cash flow, and are exceptionally cheap.

2 High-Yield Dow Stocks That Are Screaming Buys and 1 That Isn't Worth Your Money

Amgen

Gilead Sciences

Merck

Novartis

Pfizer

Sanofi

First-quarter earnings kick off in a big way on Friday with the major banks posting their results.

Why 7 of the Highest-Yielding ‘Strong Buy' Health Care Stocks Are the Absolute Best 2023 Buys

Walgreens' free cash flow wasn't strong enough in recent quarters to support its dividend payments. Walgreens has been spending billions on its U.S. healthcare segment, which isn't profitable.

Will Walgreens Be the Next Big Stock to Cut Its Dividend?

Acquisitions have played a big part in CVS' growth strategy -- helped by strong free cash flow. Walgreens has been investing billions in growth, mainly focused on primary care clinics.

Better Growth Stock: CVS Health vs. Walgreens Boots Alliance

DEERFIELD, Ill.--(BUSINESS WIRE)--Today, Walgreens nationwide kick off sales and in-store donations for the ninth annual Red Nose Day campaign to support healthy communities and help end the cycle of child poverty. Now through May 31, customers can visit Walgreens and Duane Reade locations and show their support by donating in-store via pin-pad or purchasing a Red Nose for $1, with all profits benefitting Red Nose Day.

Walgreens Returns as the Exclusive Retail Partner of Red Nose Day to Help Ensure a Healthy Future for All Children and End Child Poverty

Energy Transfer LP Unit

Diamondback Energy

Altria

Prudential Financial

When only eight stocks accounted for the majority of the gains in the S&P 500 for the first quarter, there must be some incredible value lurking for investors, especially as we now head towards the “sell in May and go away” time of the year.

Dividend Lovers Load Up on 7 Surprising Value Blue Chips With Huge Yields

PetMed Express

Companies need to grow their earnings to sustainably increase their dividends. Walgreens is struggling to drive fresh growth in its core segments.

2 Popular Dividend Stocks That Aren't as Safe as They Seem

Paramount Global

Visa

Although bear markets can be scary, they represent surefire buying opportunities for long-term investors. Four stocks have the sustained catalysts needed to deliver a triple-digit return, inclusive of dividends, over the next five years.

4 Time-Tested Stocks That Can Safely Double Your Money by 2028

Peter Lynch is best known as a growth investor, not a dividend investor. However, he has been very successful with dividend stocks too in his career. His writings have shared his selection criteria extensively.

Walgreens Vs. CVS: If Peter Lynch Picked Dividend Stocks

Amcor Plc

Franklin Resources

Chevron

Essex Property Trust

Federal Realty Investment Trust

Medtronic

Stanley Black & Decker

Sysco

T. Rowe Price Group

V.F.

"Dividend Aristocrats in the S&P 500 Index have raised their annual payouts every year for at least 25 consecutive years." - Kiplinger.com/Investing. 67 Aristocrats, screened as of April 5, 2023, represented all eleven Morningstar Sectors. Broker estimated top ten net gains ranged from 14.14%-42.97% topped by SWK & VFC.

4 Dividend Aristocrat Buys For April + 2 To Watch

Dow stock Walgreens Boots Alliance Inc (NYSE:WBA) is a  historical underperformer  in the second quarter.

Signal Says Steer Clear of This Blue Chip Stock

IQVIA Hlds

Southwest Airlines

Newell Brands

ON Semiconductor

Subscribers to  Chart of the Week  received this commentary on Sunday, April 2.

50 Second Quarter Stocks to Watch

Dividend growth stocks are alluring because their income stream grows over time. Walgreens is seeing its top line sputter while its bottom line collapses.

Better Dividend Growth Stock In 2023: Walgreens vs. CVS

Enterprise Products Partners

PennantPark Floating Rate Capital

Since 1950, stock market corrections have occurred, on average, every 1.87 years. Significant stock market pullbacks are a surefire buying opportunity for patient investors.

3 Magnificent Dividend Stocks That Can Safely Turn $300,000 Into $1 Million by 2035

Williams-Sonoma

The S&P 500 tanked around 40% during the Great Recession, and many stocks suffered big declines. Walmart and Walgreens were two stocks that outperformed as their businesses proved to be essential.

News for Walgreens Stock (WBA)